25 March 2021 Ankylosing Spondylitis Biologics Conditions Scleroderma Considering Taltz withdrawal in PsA patients?
18 March 2021 Ankylosing Spondylitis Biologics Cognitive Therapies FDA approves Actemra for scleroderma lung
10 March 2021 Conditions Research Spondyloarthritis Biobank paves future for musculoskeletal research
10 March 2021 Biologics Communicable Diseases Gout Spondyloarthritis RA patients report upadacitinib equal to or better than adalimumab
3 March 2021 Exercise osteomyelitis Spondyloarthritis Barriers to exercise – targeting RA patients who most need help
